Keyword: pharma

Egis Pharmaceuticals Plc. Expands Its Portfolio with a Well-Known Product Line

Egis Pharmaceuticals has announced that, backed by the Hungarian Competition Authority´s official certification, it has acquired one of Hungary´s well-known, locally applied dermatological product lines from Teva Pharmaceutical Industries Ltd. This move aims to strengthen Egis´s position in the Hungarian over-the-counter (OTC) market.

More

Agreement for Biosimilar Candidates in Key Central and Eastern European Markets

• mAbxience and Egis collaborate on the commercialization of two biosimilar candidates • The agreement covers eight Central and Eastern European countries with the potential for expansion into additional territories • mAbxience will serve as the marketing authorization holder, while Egis will manage commercialization in the designated regions

More

Csaba Poroszlai elected vice president of MAGYOSZ

Mr. Csaba Poroszlai, CEO of Egis and dr Tamás Rónay CEO of Sanofi-Aventis and Chinoin were elected vice presidents of the Hungarian Pharmaceutical Manufacturers’ Association (MAGYOSZ) at the Association’s annual general meeting. The executive director of Meditop Kft., dr Dávid Greskovits, will hold the position of president for another three years. Mr. Csaba Poroszlai has also become the member of the presidential board.

More

Discover the Hungarian Medicine brand

It has been almost 110 years since dr. Sándor Balla, the Hungarian pharmacist fulfilled his dream and the predeccessor of Egis was established in Budapest. Ever since then, our objective has remained unchanged: to provide Hungarian medicines of the highest quality to people, so that they can lead a long and healthy life.

More

Pharmaceutical industry is one of the key players of the Hungarian economy

The performance of the Hungarian pharmaceutical industry in the last ‘peaceful year’ before the coronavirus epidemic was reviewed in a comprehensive analysis by Nézőpont Institute on behalf of 16 pharmaceutical companies of the Hungarian Pharmaceutical Manufacturers Association (MAGYOSZ).

More
Channels
Egis World
Egis' products are sold to 100 countries.
Our People
Our mission is to serve people with all of our skills, ensuring that they live a long and healthy life
Health
In the 2022/2023 business year, the company’s product portfolio consisted of 653 products
Innovation
In the 2022/2023 business year, we spent EUR 48 million on research and development
Corporate Social Responsibility
Healthcare and sharing knowledge are in the heart of our CSR activities
Events
Our highlighted past and future events you shouldn't miss

Cookie Settings

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

Cookies necessary for basic functioning

These cookies ensure the appropriate functioning of the website, facilitate its use and collect information on its use without identifying visitors.

Functional cookies

In order to enhance the user experience, we use cookies which record the use of certain functions of the website, thus enabling users to have the same settings at the time of their next visit.

Cookies for statistical purposes

They provide statistical data on the performance of the website (such as number of page loads, average time spent on the website) in order to collect data for the operator of the website on the website usage patterns of users. These cookies do not identify visitors, information collected by them relate to the number of subpages visited by the user, the length of each session, the types of error messages, etc. Cookies for statistical purposes are automatically placed on the user’s devices during browsing, and you can delete such cookies in the browser settings.
Details
I Agree
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox